CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Ivermectin TabletsWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)


Name (Synonyms) Correlation
drug1357 Lopinavir / Ritonavir plus Ribavirin Wiki 1.00

Correlated MeSH Terms (3)


Name (Synonyms) Correlation
D013577 Syndrome NIH 0.11
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Use of Ivermectin as a Prophylactic Option in Asymptomatic Family Close Contact for Patient With COVID-19

asymptomatic family close contact of confirmed COVID -19 patient will receive prophylactic ivermectin and will be followed up for 14 days for any symptoms & diagnosis of COVID -19

NCT04422561 COVID Drug: Ivermectin Tablets

Primary Outcomes

Description: history taking

Measure: appearance of symptoms ( fever ,cough, sore throat, myalgia,diarrhea, shortness of breath)

Time: within 14 days after enrollement

Secondary Outcomes

Description: by swab

Measure: development of COVID

Time: within 14 days after enrollement


No related HPO nodes (Using clinical trials)